Wednesday, June 10

Browsing: Tolerability

Survivors

Safety, Tolerability, and the AE Profile of SC Q4W in Cohort 5

By NewsCancerMay 26, 20260

Dr. Goldberg reviews the safety and tolerability profile of subcutaneous amivantamab Q4W plus lazertinib in PALOMA-2 cohort 5 and the…

Treatments

Balancing Efficacy and Tolerability With TKIs in Advanced Renal Cell Carcinoma

By NewsCancerMay 4, 20260

In this segment on advanced renal cell carcinoma, Dr. Ornstein asks how clinicians differentiate among VEGF receptor targeted therapies when…

Survivors

Managing Tolerability and Dose Optimization in Advanced Renal Cell Carcinoma

By NewsCancerApril 13, 20260

In this segment on advanced renal cell carcinoma, Dr. Ornstein emphasizes that treatment is only effective if patients are able…

Diagnosis

Berzosertib Combo Displays Safety and Tolerability in Head and Neck Cancer

By NewsCancerMarch 27, 20260

The addition of berzosertib (VX-970) to cisplatin and radiotherapy displayed safety and tolerability but did not meet the preliminary efficacy…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.